We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 25.00
Ask: 30.00
Change: 2.50 (10.00%)
Spread: 5.00 (20.00%)
Open: 27.50
High: 27.50
Low: 27.40
Prev. Close: 25.00
KRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

7 Mar 2024 07:00

RNS Number : 9071F
KRM22 PLC
07 March 2024
 

KRM22 plc

("KRM22" or the "Company")

Board Changes

 

KRM22 plc, (AIM: KRM) the technology and software investment company that focuses on risk management for capital markets, today announces the following Board changes as it enters its next phase of growth.

 

Dan Carter has been appointed CEO and a Director of the Company, whilst Stephen Casner, a founder director and the former CEO of the Company is leaving to pursue private equity opportunities in the United States.

 

Dan has a wealth of experience in capital markets technology having joined KRM22 in June 2018 and has since served in both Sales and Customer Services roles, then most recently as the Company's Chief Services Officer. Prior to joining KRM22 Dan worked at ION, and prior to its acquisition by ION, FFastFill, where he worked in product management and customer service roles.

 

Additionally, Keith Todd will relinquish his role as Executive Chairman of KRM22 whilst remaining an Executive Director of the Company and Garry Jones, Non-Executive Director, will succeed Keith as Non-Executive Chairman of the Company.

 

Kim Suter, CFO and Director of the Company, Sandy Broderick, Non-Executive Director and Chairman of the Remuneration Committee and Nomination Committee, and Steve Sparke, Non-Executive Director and Chairman of the Audit Committee will continue in their respective roles.

 

The Board changes referenced above are taking place with immediate effect.

 

Keith Todd, former Executive Chairman at KRM22 commented: "After nearly six years since our IPO, it's time to make these Board changes when the growth trajectory and outlook of the Company is strong. I would like to thank Stephen for his contribution to KRM22 from the inception. Dan is an excellent candidate for the CEO role who is well equipped to lead KRM22 through its next phase of growth and Garry will provide experienced council and continuity as Non-Executive Chairman of the Company."

 

Dan Carter, CEO at KRM22 commented: "I'm delighted to be appointed as CEO of KRM22 and, following the foundations put in place by both Keith Todd and Stephen Casner, I look forward to working with the KRM22 Board, customers and stakeholders to continue to grow the business inline with the previously stated strategy and moving towards a £10m ARR business."

 

Garry Jones, Chairman at KRM22 commented: "Over the last few years KRM22 has established itself as a market leader in risk management technology with a strong client list of major financial institutions. The management changes announced today lay the groundwork for significant future growth and renewed vigour, whilst creating economic and business value for our shareholders, customers and employees."

 

Stephen Casner, former CEO at KRM22 commented: "It's been a pleasure to have been a key part of KRM22 and serving as CEO for the past two years. I am very proud of the team we have built and look forward to their success. It is a natural juncture for me to hand over the reins to Dan, who I have worked closely with for over five years."

 

 

For further information please contact:

 

KRM22 plc

Garry Jones, Chairman

Dan Carter, CEO

Kim Suter, CFO

 

InvestorRelations@krm22.com

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Carl Holmes / George Dollemore (Corporate Finance)

Sunila de Silva (ECM)

 

+44 (0)20 7220 0500

 

 

The information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' trading and corporate risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com

 

 

The following information is disclosed in relation to Daniel Laurance Murray Carter, age 37, pursuant to Schedule Two paragraph (g) and Rule 17 of the AIM Rules for Companies:

 

 

Current Directorships / Partnerships:

 

None

 

Previous Directorships / Partnerships (held in the past five years)

 

None

 

 

Mr Carter currently holds 5,000 ordinary shares in the Company, representing 0.01 per cent. of the issued share capital of the Company and has 182,997 share options and 64,794 Restricted Stock Units in the Company.

 

There is no further information to be disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAQKABPDBKBPNK
Date   Source Headline
16th Apr 20247:00 amRNSDirector Dealings
15th Apr 20247:00 amRNSNew Customer Contract
10th Apr 20247:00 amRNSIssue of Equity
7th Mar 20247:00 amRNSBoard Changes
21st Feb 20247:00 amRNSTrading Update
1st Dec 20237:00 amRNSIssue of Restricted Stock Units
26th Sep 20237:00 amRNSInterim Results
27th Jul 202311:48 amRNSResult of General Meeting
21st Jul 20237:00 amRNSDirector Dealing
20th Jul 20237:00 amRNSHalf Year Trading Update
4th Jul 20237:00 amRNSPosting of Accounts, Circular and Notice of GM
30th Jun 202312:41 pmRNSResult of AGM
27th Jun 20237:00 amRNSFinal Results
19th Jun 20237:00 amRNSNew Debt Facility
8th Jun 20237:00 amRNSAnnual Report and Notice of AGM
16th Dec 20223:15 pmRNSIssue of Options
20th Sep 20227:00 amRNSInterim Results
13th Jun 202210:00 amRNSHolding(s) in Company
5th May 202212:00 pmRNSResult of AGM
20th Apr 20222:30 pmRNSDirector Dealing
12th Apr 20227:00 amRNSNotice of AGM and Posting of Annual Report
7th Apr 20224:30 pmRNSHolding(s) in Company
28th Mar 20225:30 pmRNSHolding(s) in Company
23rd Mar 20227:00 amRNSFinal Results
15th Mar 20227:00 amRNSProduct Launch Under Distribution Agreement
1st Mar 20227:00 amRNSUpdate re Annual Results (Change of Date)
31st Jan 20227:00 amRNSTrading Update
5th Jan 202210:47 amRNSHolding(s) in Company
30th Dec 20219:47 amRNSSubscription Completion, Executive Changes and TVR
22nd Dec 20217:00 amRNSSubscription Update
22nd Nov 20217:00 amRNSHolding(s) in Company
1st Nov 20217:00 amRNSSubscription Agreement and Trading Update
20th Oct 20213:43 pmRNSHolding(s) in Company
16th Sep 20212:38 pmRNSDirector/PDMR Shareholding
13th Sep 20219:52 amRNSDirector/PDMR Shareholding
10th Sep 20212:48 pmRNSDirector/PDMR Shareholding
8th Sep 202112:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
1st Sep 20217:00 amRNSInterim Results
30th Jul 20217:00 amRNSContract Extension
22nd Jul 20217:00 amRNSHalf Year Trading Update
24th Jun 20217:00 amRNSKRM22 announces partnership with Waymark Tech
28th Apr 20211:29 pmRNSResult of AGM
19th Apr 20217:00 amRNSExercise of options and total voting rights
26th Mar 20213:24 pmRNSHolding(s) in Company
23rd Mar 20218:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20215:39 pmRNSHolding(s) in Company
16th Mar 202111:06 amRNSTechnology Demonstration
16th Mar 20217:00 amRNSFinal Results
24th Feb 20217:00 amRNSKRM22 announces new partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.